Latest news
Annual General Meeting Strengthens the Board of Directors with Financial and Regulatory Competencies
Financial .2013Oslo, Norway, May 15, 2013 - Bionor Pharma's shareholders appointed Algeta's CFO, Øystein Soug, and Ferring's Senior Vice President of Regulatory Affairs, Marianne Kock to the Board of Directors at the Annual General Meeting.
Minutes from the Annual General Meeting of Bionor Pharma ASA
Financial .2013Oslo, 15 May 2013.The Annual General Meeting of Bionor Pharma ASA today adopted all the items as proposed on the agenda.
Annual General Meeting Strengthens the Board of Directors with Financial and Regulatory Competencies
Financial .2013Oslo, Norway, May 15, 2013 - Bionor Pharma's shareholders appointed Algeta's CFO, Øystein Soug, and Ferring's Senior Vice President of Regulatory Affairs, Marianne Kock to the Board of Directors at the Annual General Meeting.
Minutes from the Annual General Meeting of Bionor Pharma ASA
Financial .2013Oslo, 15 May 2013.The Annual General Meeting of Bionor Pharma ASA today adopted all the items as proposed on the agenda.
Featured content
Our Clinical Advisory Board consists of prominent experts within the fields of vaccines and immunology. Meet them here.
Read more about Clinical Advisory Board
Video with Professor of Oncology at St. George's University, Angus Dalgleish, and CEO of Celgene Global Health, Jerome Zeldis.
Read more about Video: HIV vaccine research
Whereas Vacc-4x appears to kill virus-producing cells, Vacc-C5 has the potential to reduce the damaging immune activation caused by HIV.
Read more about Aim to cure HIV infection
We are currently developing a ‘universal’ vaccine with the aim of providing protection against several strains of influenza A viruses.
Read more about Universal Influenza Vaccine